Pharm Exec's Industry Audit 2019

In this ISSUE

Biosensors in Pharma: A Dose of Optimism

Emerging Pharma Must Pick Up Pace in Analytics Arms Race

Lay the Tech Foundation for IPO Success

Top Story

The Quest to Measure Drug Effectiveness

A formal effort is underway in Europe to gather concrete clues on the value of real-world evidence in payer decision-making. Reflector reports
… /Read more/

Order-To-Cash Management Fundamentals to Increase Profitability and Reduce Risk
Wednesday, November 20, 2019 at 10am EST| 9am CST| 3pm GMT| 4pm CET

Interview

Bayer Focuses on Science and Innovation for the Future

Sebastian Guth, President of Pharmaceuticals, Americas Region for Bayer, shares the company's long-term vision
… /Read more/

A Modern Approach to Global Growth & Compliance in Life Sciences: A Story of Digitalization at Boehringer Ingelheim
Thursday, October 31, 2019 at 11am EDT

M&A

Leading Integration: Six Steps to Preserve Acquisition Value

Healthy companies with coherent integration strategies will benefit from applying six lessons to ensure successful integration, writes Mark Bouch.
… /Read more/

Japan Oncology Market – Best in Class Practices for Advancing Patient Outcomes
Tuesday, October 15, 2019 at 5pm JST
Tuesday, October 29, 2019 at 11am JST

Marketing

Towards a Meaningful Customer-Centric Digital Strategy

Without a clear, customer-centric digital experience at the core of every brand, it is impossible to deliver on the brand promise at scale, write Dr. Pamela Walker and Tom Murdoch
… /Read more/

Launch Strategies: Trends and Challenges for Biotech Companies
Wednesday, October 23, 2019 at 10am EDT

Audio

The Pharm Exec Podcast: Pharma Reputation

Sven Klingemann, research director at Reputation Institute, talks about pharma’s negative public perception and what the industry can do to improve it
… /Click here to listen/

Japan Oncology Market – Best in Class Practices for Advancing Patient Outcomes
Tuesday, October 15, 2019 at 5pm JST
Tuesday, October 29, 2019 at 11am JST

Launching Medical Devices in the Japanese Market - How to navigate regulatory and reimbursement approval
Thursday, October 31, 2019 at 11am EDT

Calendar

/ November 13–14: 6th Annual Global Compliance Congress /

London, UK

/ November 19–21: Clinical Supply Chain Europe /

Barcelona, Spain

/ December 11: eyeforpharma Awards 2019 /

Philadelphia, PA

/ December 11–12: Pharmaceutical Drug Pricing Strategies Summit /

London, UK

/ December 11: Clinical Trial Financial Management /

Philadelphia, PA

/ February 27–28: Pharmaceutical Compliance Congress Asia /

Kyoto, Japan

/ March 18–19 2020: World Pharma Pricing Market Access & Evidence Congress /

Amsterdam, The Netherlands

Industry update

// Santhera Pharmaceuticals (Prattein, Switzerland) appointed Dario Eklund as CEO, effective December 1, 2019. Thomas Meier will continue as a Board Member and will chair the newly formed Board of Director’s Scientific Committee. He will also serve as a special advisor to Mr. Eklund. // Arthur D. Little (London, UK) Dr. Ulrica Sehlstedt as the new Global Practice Leader for its Global Healthcare & Life Sciences Practice. // Oxford BioDynamics (Oxford, UK) appointed Professor Iain McInnes to its Scientific Advisory Board. // Mundipharma Pharmaceuticals Limited (Dublin, Ireland) announced the appointment of Matthew Homent as Ireland Country Manager, a position he has held on an interim basis since April 2019.

update my profile / advertise with us / print subscribe / digital subscribe / visit pharmexec.com